Cart
sales@molnova.com
PA3552-IN-1
CAS No. 1008121-12-7
PA3552-IN-1( —— )
Catalog No. M36072 CAS No. 1008121-12-7
PA3552-IN-1 is an antibiotic adjuvant that can reduce the expression of PA3552 and restore the sensitivity of MDR Pseudomonas aeruginosa DK2 strain to Polymyxin B.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 52 | Get Quote |
|
| 10MG | 92 | Get Quote |
|
| 25MG | 182 | Get Quote |
|
| 50MG | 302 | Get Quote |
|
| 100MG | 446 | Get Quote |
|
| 500MG | 963 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePA3552-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPA3552-IN-1 is an antibiotic adjuvant that can reduce the expression of PA3552 and restore the sensitivity of MDR Pseudomonas aeruginosa DK2 strain to Polymyxin B.
-
DescriptionPA3552-IN-1 (compound 15) is an antibiotic adjuvant that restores sensitivity of MDR P. aeruginosa DK2 strain to Polymyxin B. PA3552-IN-1 can reduce PA3552 expression.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1008121-12-7
-
Formula Weight310.67
-
Molecular FormulaC13H8ClFN2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 13.89 mg/mL (44.71 mM)
-
SMILESOc1ccc(F)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lu T, et, al. Novel niclosamide-derived adjuvants elevating the efficacy of polymyxin B against MDR Pseudomonas aeruginosa DK2. Eur J Med Chem. 2022 Jun 5;236:114318.?
molnova catalog
related products
-
Metronidazole Benzoa...
Metronidazole Benzoate (Benzoyl metronidazole) is a derivative of Metronidazole and benzoic acid, which has antibacterial, anti-parasitic and anti-trichomonas functions and is often used to treat infections caused by anaerobic bacteria.
-
PAβN dihydrochloride
PAβN dihydrochloride is an inhibitor of efflux pump. PAβN reduces the MICs in nine ciprofloxacin-resistant isolates, and in four of these, PAβN increases the susceptibility by twofold.?
-
PGLa
PGLa is a cationic antimicrobial peptide (AMP) originally isolated from frog. It has been shown to have antibacterial,antifungal,and antiviral,activities.
